<DOC>
	<DOCNO>NCT00198471</DOCNO>
	<brief_summary>The purpose study assess efficacy intravitreous injection Vitrase induce posterior vitreous detachment ( PVD ) subject moderate severe non-proliferative diabetic retinopathy .</brief_summary>
	<brief_title>Assessment Intravitreous Injections Vitrase Inducing Posterior Vitreous Detachment</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<mesh_term>Vitreous Detachment</mesh_term>
	<criteria>Moderately severe severe nonproliferative diabetic retinopathy Best Corrected Visual Acuity ( BCVA ) Early Treatment Diabetic Retinopathy Study ( ETDRS ) pinhole 20/320 good study eye &amp; 20/50 good nonstudy eye . Contraindications hypersensitivities Vitrase anesthesia Any significant illness could expect interfere trial Prior Vitrase therapy Either past diagnosis clinically significant macular edema ( CME ) study eye require treatment current CME may require focal laser treatment within next 30 day For either eye : ongoing ocular infection , inflammation history herpetic corneal lesion ; intravitreous injection within 30 day ; glaucoma ; intraocular pressure ( IOP ) less 5mmHg ; retinal detachment ocular tumor For study eye : vascular occlusive disease fundus ; corneal , lenticular ocular medium abnormality ; significant ocular trauma within 6 month ; previous vitrectomy ; prior laser treatment , cryoretinopexy intraocular surgery ; either partial complete posterior vitreous detachment ( PVD ) ; myopia 6 spherical diopter and/or axial length exceed 26mm ; significant retinal pathology</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>